Turn Therapeutics TTRX
NASDAQ TTRX
$9.90 +0.11 (+1.12%)
As of: Nov 10, 2026 · 1:37 PM EST

Turn Therapeutics (TTRX) EBIT (2024 - 2026)

Updated

Turn Therapeutics' EBIT was -$1.63 million in Q2 2026, compared with -$1.37 million a year earlier.

Analysis

Turn Therapeutics (TTRX) EBIT (2024 - 2026) Analysis & Trends

On a trailing twelve-month basis, Turn Therapeutics' EBIT was -$6.98 million through Jun 30, 2026; for FY2025, it was -$5.86 million.

  • In earlier years, EBIT was -$1.8 million in FY2024.
  • Quarterly EBIT has moved between -$2.19 million (Q4 2025) and -$328,957 (Q4 2024) over five years.
  • Per Business Quant data, TTRX's EBIT in the three quarters before Q2 2026 was -$1.25 million (Q1 2026), -$2.19 million (Q4 2025) and -$1.91 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 12.79 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 6.18 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 6.27 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 5.59 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 3.16 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 3.71 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 3.46 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 5.47 Bn
10 Turn Therapeutics 300.41 Mn 273.52 Mn - -1.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.63 Mn
Mar 31, 2026 -1.25 Mn
Dec 31, 2025 -2.19 Mn
Sep 30, 2025 -1.91 Mn
Jun 30, 2025 -1.37 Mn
Mar 31, 2025 -384,997.00
Dec 31, 2024 -328,957.00
Sep 30, 2024 -672,992.00
API Access

Turn Therapeutics EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=TTRX&period=max&api_key=YOUR_API_KEY